NASDAQ:TNGX | Free Cash Flow | Tango Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$44.36M-$2,000.00-$44.36M
2025-12-31-$29.72M$222,000.00-$29.94M
2025-03-31-$41.7M$51,000.00-$41.75M
2024-12-31-$36.65M$124,000.00-$36.77M
2024-03-31-$37.86M$195,000.00-$38.05M
2023-12-31-$27.47M$226,000.00-$27.69M
2023-03-31-$34.91M$620,000.00-$35.53M
2022-12-31-$28.27M$1.04M-$29.31M
2022-03-31-$29.67M$1.56M-$31.23M
2021-12-31-$16.9M$696,000.00-$17.6M
2021-03-31-$13.61M$165,000.00-$13.78M
2020-12-31-$18.06M$456,000.00-$18.52M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$138.89M$1.05M-$139.93M
2024-12-31-$131.5M$754,000.00-$132.26M
2023-12-31-$117.98M$1.53M-$119.51M
2022-12-31-$109.08M$7.69M-$116.77M
2021-12-31-$59.53M$1.84M-$61.36M
2020-12-31$70.07M$1.11M$68.97M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.